A personal care composition comprising: a) from 0.01 wt.% to 10 wt.% of a galactomannan polymer derivative having a mannose to galactose ratio of greater than 4:1 on a monomer to monomer basis, said galactomannan polymer derivative selected from the group consisting of a cationic galactomannan polymer derivative and an amphoteric galactomannan polymer derivative having a net positive charge; i) wherein said galactomannan polymer derivative has a molecular weight from 5,000 to 3,000,000; and ii) wherein said galactomannan polymer derivative has a cationic charge density from 0.9 meq/g to 7 meq/g; b) from 5 wt.% to 35 wt.% of an anionic surfactant system, said anionic surfactant system comprising at least one anionic surfactant and having an ethoxylate level and an anion level, i) wherein said ethoxylate level is from 1 to 6, and ii) wherein said anion level is from 1.5 to 6; c) an aqueous carrier; and d) as a conditioning agent, silicone; wherein the weight ratio of said conditioning agent(s) to said galactomannan polymer derivative is at least 2:1; wherein the composition further comprises 0.025 wt.% to 5 wt.% of a synthetic cationic deposition polymer having a molecular weight from 1,000 to 5,000,000 and a charge density from 0.5 meq/g to 10 meq/g; and wherein the personal care composition comprises maximally 10 wt.% of galactomannan polymer derivatives, selected from the group consisting of cationic galactomannan polymer derivatives and amphoteric galactomannan polymer derivatives having a net positive charge, having a mannose to galactose ratio of greater than 2:1 on a monomer to monomer basis, a molecular weight from 1,000 to 10,000,000, and a cationic charge density from 0.7 meq/g to 7 meq/ g. a) from 0.01 wt.% to 10 wt.% of a galactomannan polymer derivative having a mannose to galactose ratio of greater than 4:1 on a monomer to monomer basis, said galactomannan polymer derivative selected from the group consisting of a cationic galactomannan polymer derivative and an amphoteric galactomannan polymer derivative having a net positive charge; i) wherein said galactomannan polymer derivative has a molecular weight from 5,000 to 3,000,000; and ii) wherein said galactomannan polymer derivative has a cationic charge density from 0.9 meq/g to 7 meq/g; i) wherein said galactomannan polymer derivative has a molecular weight from 5,000 to 3,000,000; and ii) wherein said galactomannan polymer derivative has a cationic charge density from 0.9 meq/g to 7 meq/g; b) from 5 wt.% to 35 wt.% of an anionic surfactant system, said anionic surfactant system comprising at least one anionic surfactant and having an ethoxylate level and an anion level, i) wherein said ethoxylate level is from 1 to 6, and ii) wherein said anion level is from 1.5 to 6; i) wherein said ethoxylate level is from 1 to 6, and ii) wherein said anion level is from 1.5 to 6; c) an aqueous carrier; and d) as a conditioning agent, silicone; wherein the weight ratio of said conditioning agent(s) to said galactomannan polymer derivative is at least 2:1; wherein the composition further comprises 0.025 wt.% to 5 wt.% of a synthetic cationic deposition polymer having a molecular weight from 1,000 to 5,000,000 and a charge density from 0.5 meq/g to 10 meq/g; and wherein the personal care composition comprises maximally 10 wt.% of galactomannan polymer derivatives, selected from the group consisting of cationic galactomannan polymer derivatives and amphoteric galactomannan polymer derivatives having a net positive charge, having a mannose to galactose ratio of greater than 2:1 on a monomer to monomer basis, a molecular weight from 1,000 to 10,000,000, and a cationic charge density from 0.7 meq/g to 7 meq/ g.